These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18753342)

  • 41. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
    Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
    J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
    Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
    Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
    Koga M; Takahashi M; Yokoyama K; Kanda T
    J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.
    Heikema AP; Bergman MP; Richards H; Crocker PR; Gilbert M; Samsom JN; van Wamel WJ; Endtz HP; van Belkum A
    Infect Immun; 2010 Jul; 78(7):3237-46. PubMed ID: 20421384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
    Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
    J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies.
    Koga M; Yuki N; Kashiwase K; Tadokoro K; Juji T; Hirata K
    J Neuroimmunol; 1998 Aug; 88(1-2):62-6. PubMed ID: 9688325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.
    Zhang M; He L; Li Q; Sun H; Gu Y; You Y; Meng F; Zhang J
    PLoS One; 2010 Nov; 5(11):e15060. PubMed ID: 21124772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
    Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
    Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
    J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How do we identify infectious agents that trigger Guillain-Barré syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis?
    Yuki N; Shahrizaila N
    J Neurol Sci; 2011 Mar; 302(1-2):1-5. PubMed ID: 21238990
    [No Abstract]   [Full Text] [Related]  

  • 52. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Neisser A; Schwerer B; Bernheimer H; Moran AP
    J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis.
    Gilbert M; Brisson JR; Karwaski MF; Michniewicz J; Cunningham AM; Wu Y; Young NM; Wakarchuk WW
    J Biol Chem; 2000 Feb; 275(6):3896-906. PubMed ID: 10660542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.
    Linton D; Karlyshev AV; Hitchen PG; Morris HR; Dell A; Gregson NA; Wren BW
    Mol Microbiol; 2000 Mar; 35(5):1120-34. PubMed ID: 10712693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
    Yuki N
    Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of four virulence genes in Campylobacter jejuni determined by PCR and sequence analysis.
    Kordinas V; Nicolaou C; Ioannidis A; Papavasileiou E; John Legakis N; Chatzipanagiotou S
    Mol Diagn; 2005; 9(4):211-5. PubMed ID: 16392901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
    Li H; Yuan J; Shen B; Sun X; Hao H
    Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.